INSIDER
01Overview02Follow the Money03Daily Brief04Live05Congress06Corporate Insiders07Government Money08Political Influence09Institutions10Washington Network11Follow the Power12Disclosure Clock13AI Investigator14Watchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

RH CHAIN…
OverviewFollow the MoneyDaily BriefLiveCongressCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
01Overview02Follow the Money03Daily Brief04Live05Congress06Corporate Insiders07Government Money08Political Influence09Institutions10Washington Network11Follow the Power12Disclosure Clock13AI Investigator14Watchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
OverviewFollow the MoneyDaily BriefLiveCongressCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
Data sources
SEC FORM 437m ago
HOUSE PTR37m ago
SEC 13F37m ago
ROBINHOOD CHAIN37m ago
SEC FORM 4/Grant or awardVerified data

Abbott Richard David reported CODX

President · Co-Diagnostics, Inc. · Common Stock

Side
A
Value
—
Shares
1,890
Price
—
Executed
May 23, 2026
Disclosed
May 27, 2026
Disclosure timeline4 days from execution to publication · legal deadline 2 business days
May 23 executedMay 27, 2026 disclosed

CODX · daily

Yahoo Finance chart API
▲Execution▼Disclosure●Material company filing●Other disclosed buy●Other disclosed sellUnofficial public endpoint; daily OHLCV, split-adjusted. Replace with a licensed feed for production.

Insider Score

Experimental signal
27/ 100 · ROUTINE
Methodology →
  • Transaction type0 / 20

    Grant or award — administrative, little informational value

  • Relative size+13 / 25

No reported dollar value · 85.6% of prior position

  • Filing timing+6 / 15

    Disclosed 3 business days after execution (deadline: 2)

  • Historical behavior+8 / 15

    First recorded trade by this actor in this security

  • Frequency & clustering0 / 15

    No clustered activity in the dataset

  • Market events0 / 10

    No material company filing within 60 days after the trade

    • The Insider Score measures how far a disclosure deviates from normal filing patterns. A high score is a prompt for research, not evidence of illegal insider trading.

    Other disclosed activity · CODX

    ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
    23
    AD
    Abbott Richard DavidPresident
    CODXCo-Diagnostics, Inc.
    Option exercise
    		M—
    1,890 sh
    		May 23, 2026May 27, 2026
    traded May 23, 2026
    		+4dSEC FORM 4

    Evidence

    23
    AD
    Abbott Richard DavidPresident
    CODXCo-Diagnostics, Inc.
    Disposition to issuer
    		D$3,448
    680 sh
    		May 23, 2026May 27, 2026
    traded May 23, 2026
    		+4dSEC FORM 4

    Evidence

    17
    BL
    Brown Brian LeeChief Financial Officer
    CODXCo-Diagnostics, Inc.
    Grant or award
    		A—
    134.2K sh
    		Nov 23, 2025Nov 24, 2025
    traded Nov 23, 2025
    		+1dSEC FORM 4

    Evidence

    13
    BL
    Brown Brian LeeChief Financial Officer
    CODXCo-Diagnostics, Inc.
    Disposition to issuer
    		D$14K
    40.7K sh
    		Nov 23, 2025Nov 24, 2025
    traded Nov 23, 2025
    		+1dSEC FORM 4

    Evidence

    21
    BL
    Brown Brian LeeChief Financial Officer
    CODXCo-Diagnostics, Inc.
    Option exercise
    		M—
    134.2K sh
    		Nov 23, 2025Nov 24, 2025
    traded Nov 23, 2025
    		+1dSEC FORM 4

    Evidence

    17
    AD
    Abbott Richard DavidPresident
    CODXCo-Diagnostics, Inc.
    Disposition to issuer
    		D$6,020
    17.2K sh
    		Nov 23, 2025Nov 24, 2025
    traded Nov 23, 2025
    		+1dSEC FORM 4

    Evidence

    21
    AD
    Abbott Richard DavidPresident
    CODXCo-Diagnostics, Inc.
    Grant or award
    		A—
    56.7K sh
    		Nov 23, 2025Nov 24, 2025
    traded Nov 23, 2025
    		+1dSEC FORM 4

    Evidence

    17
    AD
    Abbott Richard DavidPresident
    CODXCo-Diagnostics, Inc.
    Option exercise
    		M—
    56.7K sh
    		Nov 23, 2025Nov 24, 2025
    traded Nov 23, 2025
    		+1dSEC FORM 4

    Evidence

    Evidence

    Verified data

    Read directly from the primary public document; every field below is as reported by the filer.

    Source

    Document
    SEC Form 4
    Publisher
    U.S. Securities and Exchange Commission (EDGAR)
    Document ID
    0002016256-26-000002
    Machine-readable
    Structured copy

    Timestamps

    Event (reported)
    May 23, 2026
    Published
    May 27, 2026
    Ingested by INSIDER
    Nov 5, 03:56 UTC
    Last re-read
    Nov 5, 03:56 UTC

    Extracted facts

    Filer
    Abbott Richard David
    Role
    President
    Transaction
    Grant or awardAs filed: “A”
    Asset
    Co-Diagnostics, Inc.
    Ticker
    CODX
    Shares
    1,890
    Price per share
    $0
    Execution date (reported)
    May 23, 2026
    Owned after transaction
    4,097 shares
    Days from execution to publication
    4

    What this establishes

    Abbott Richard David filed this Form 4 reporting a grant or award of CODX on May 23, 2026. It became public on May 27, 2026. The filing establishes the reported transaction and the filer's stated role. It does not establish why the trade was made or what the filer knew.

    Extraction

    Method
    Form 4 XML
    Confidence
    1.00
    President
    Abbott Richard Davidcik:0002016256
    Issuer
    Co-Diagnostics, Inc.cik:0001692415

    Revision history · 0

    No field has changed since this record was first ingested.

    Company events

    No records

    No material filings recorded for this issuer.